| Autor: |
Kumar M; Department of Pathology, King George Medical University, Lucknow 226003, Uttar Pradesh, India., Ali W; Department of Pathology, King George Medical University, Lucknow 226003, Uttar Pradesh, India., Yadav K; Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow 226003, Uttar Pradesh, India., Kaumri S; Department of Pathology, King George Medical University, Lucknow 226003, Uttar Pradesh, India., Mishra S; Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow 226003, Uttar Pradesh, India., Nardi P; Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy., Iellamo F; Division of Cardiology and CardioLab, Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy., Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy., Pradhan A; Lari Cardiology Center, King George Medical University, Lucknow 226003, Uttar Pradesh, India., Perrone MA; Division of Cardiology and CardioLab, Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy. |
| Abstrakt: |
Background: Coronary artery disease (CAD) is the leading cause of death worldwide. High-Density lipoprotein (HDL) is a well-established marker associated with CAD. The current research goes beyond the conventional HDL-C measurement in previous studies and dives into the functional intricacies of HDL. By understanding how HDL works, rather than just how much of it exists, we can better tailor diagnostic and therapeutic strategies for CAD and related conditions. Hence, the current study quantifies the serum levels of two novel HDL-associated markers, Paraoxonase-1 (PON-1) and Scavenger Receptor Class B Type 1 (SRB-1), in CAD cases vs. controls. Methods: A total of 92 subjects, including 69 CAD and 23 healthy controls, were included, based on the prevalence of the disease. Further, based on the severity of the disease, CAD cases were subcategorized as CAD-I, -II, and -III. Serum PON-1 and SRB-1 levels were measured and compared between patient and control groups. Results: The levels of PON-1 and SRB-1 (32.6 ng/mL and 12.49 ng/mL) were significantly lower in CAD patients vs. the healthy control, at 60.36 ng/mL and 15.85 ng/mL, respectively ( p < 0.000). A further intergroup comparison showed a statistically significant difference between the CAT-I and -III for PON-1 ( p < 0.025), the CAT-I and -III, and CAT-II and -III for SRB-1 ( p < 0.000). The receiver operating characteristics (ROC) curve showed cutoff values of 48.20 ng/mL and 14.90 ng/mL for PON-1 and SRB-1. Conclusions: The current study found that serum levels of HDL-associated PON-1 and SRB-1 are significantly lower in CAD cases, and were also inversely related to the increasing severity of coronary artery disease. This inference implies that serum PON-1 and SRB-1 could be used as non-invasive tools for the identification of coronary atherosclerosis and risk assessment in CAD cases. |
